Healthcare / Medical Care FacilitiesKuala Lumpur
$0.53
+0.00 (+0.95%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $13.5M · quality 62.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$288M
P/E
26.5x
↑EV/EBITDA
8.0x
↓ROE
18.9%
↑Gross Margin
78.3%
↑Debt/Equity
0.67
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.9%
FCF CAGR
+18.0%
FCF margin
19.3%
FCF / Net income
1.88x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $135.7M · net income $13.9M · FCF $26.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $135.7M | $135.7M | $127.7M | $114.0M | $108.0M |
| Net Income | $13.9M | $13.9M | $13.0M | $12.9M | $14.7M |
| EBITDA | $39.6M | $39.6M | $37.1M | $31.3M | $32.6M |
| EPS | — | — | 0.02 | 0.02 | 0.03 |
| Gross Margin | 78.3% | 78.3% | 79.5% | 78.4% | 78.1% |
| Operating Margin | 16.9% | 16.9% | 17.6% | 18.6% | 22.8% |
| Net Margin | 10.3% | 10.3% | 10.2% | 11.3% | 13.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.67 | 0.67 | 0.87 | 0.53 | 0.45 |
| Current Ratio | 1.58 | 1.58 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $26.2M | $26.2M | $-2.1M | $13.5M | $15.9M |
| Returns | |||||
| ROE | 18.9% | 18.9% | 19.2% | 20.5% | 25.3% |
| Valuation | |||||
| P/E | 26.50 | 26.50 | 25.97 | 26.96 | 29.03 |
| EV/EBITDA | 8.01 | 8.01 | 10.20 | 11.65 | 13.34 |
| P/B | 3.90 | 3.90 | 4.98 | 5.52 | 7.34 |
| Growth & Yield | |||||
| Revenue Growth | 6.3% | 6.3% | 12.1% | 5.5% | — |
| EPS Growth | — | — | 0.4% | -13.9% | — |
| Dividend Yield | 2.6% | 2.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+4.6%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → n/d
Residual
+1.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.